Regional Health Properties, Inc. (RHEP) Fair Value & Analysis
Healthcare · US · Market cap $4.2M
What is Regional Health Properties, Inc. really worth?
A solid business, but trading 17% above our fair value of $0.9155.
Risks
Fair value as of: Aug 27, 2026
From 4 valuation models · updated 5 days ago
Fair value updated Aug 27, 2026, revised from $0.9046 to $0.9155 (+1.2%) since Aug 13, 2026. Share price +2.2% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
- The price sits in the upper half of our model range, so the margin of safety is thin.
- Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 27, 2026.
How to read this chart
60‑month range $1.00 – $16.30 · fair‑value band $0.6858 – $1.15 · the $1.07 price screens above the $0.9155 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 27, 2026.
Analysis
Regional Health Properties, Inc. (RHEP) currently trades at $1.07, while our model-based Fair Value estimate is $0.9155, implying the stock looks roughly 16.9% overvalued today. The Quality Score stands at 52/100 (solid quality), in the Healthcare sector. Bull case: the Multiples group reads highest at a median of $2.57 per share, and 3 of the 4 models we run sit above the $1.07 price. Bear case: the Asset-Based group reads lowest at $0.8600, and 1 of the 4 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, Regional Health Properties, Inc. generated revenue of $66.2M at a net margin of 5.2%. Revenue grew 194.7% year over year. It earns a return on equity of 31.8%. Net debt stands at $42.5M. Fundamentals as of Aug 27, 2026
Our scenario range runs from $0.6858 (bear case) to $1.15 (bull case); at $1.07, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 69% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −14%, RHEP screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $1.16 per share, which is 127.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 4 models by family
Widest divergence: Economic Profit ($9.34) versus Asset-Based ($0.8600). Highest evidence: P/S Multiple (58).
Notify me when RHEP reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 27, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 46 · Market factors (momentum, volatility) 21
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Regional Health Properties, Inc., together with its subsidiaries, operates as a healthcare company that owns, operates, and invests in healthcare real estate and operating businesses.
Full company description
Regional Health Properties, Inc., together with its subsidiaries, operates as a healthcare company that owns, operates, and invests in healthcare real estate and operating businesses. The company owns and operates skilled nursing and senior housing communities that provide a range of healthcare and residential services, including sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative therapy, memory care, Alzheimer's and dementia care, and senior living services. It also engages in the owning and leasing/subleasing of healthcare facilities, including skilled nursing facilities and assisted living facilities to third-party tenants. The company was formerly known as AdCare Health Systems, Inc. and changed its name to Regional Health Properties, Inc. in October 2017. Regional Health Properties, Inc. was incorporated in 1991 and is headquartered in Atlanta, Georgia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Regional Health Properties, Inc. reported revenue of $53.2M in FY2025 versus $26.7M in FY2021, a compound +18.8%/yr. Reported net income was $3.4M in FY2025.
RHEP screens 17% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 267 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 27, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $417.82 | $547.67 | +31% |
| Fresenius SE FRE | €45.25 | €32.15 | −29% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 241.00 SAR | 112.37 SAR | −53% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | −46% |
| Tenet Healthcare Corporation THC | $266.80 | $330.25 | +24% |
| DaVita Inc DVA | $180.68 | $186.49 | +3% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,818 | ₹2,955 | −66% |
| Fresenius Medical Care AG FME | €39.92 | €71.28 | +79% |
| Aier Eye Hospital Group 300015 | ¥8.25 | ¥7.67 | −7% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,005 | ₹284.87 | −72% |
Compare Regional Health Properties, Inc. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Regional Health Properties, Inc. (RHEP) overvalued or undervalued?
What is the fair value of RHEP?
What is the quality score of RHEP?
What is the revenue of Regional Health Properties, Inc. (RHEP)?
What is the net profit margin of RHEP?
Watch Regional Health Properties, Inc. in the live analysis
One click puts Regional Health Properties, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.